Immunoablation and aHSCT for aggressive multiple sclerosis

Lancet. 2017 Mar 4;389(10072):907-908. doi: 10.1016/S0140-6736(17)30605-0.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Multiple Sclerosis*
  • Transplantation Conditioning*
  • Transplantation, Autologous